Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Jiangxi Rimag Group Co., Ltd. Class H ( (HK:2522) ) just unveiled an update.
Jiangxi Rimag Group Co., Ltd. has announced an extraordinary general meeting to be held on February 18, 2025, in Beijing. The agenda includes approving amendments to its Articles of Association, bank financing proposals, and authorizing its chairman, Mr. Chen Zhaoyang, to enter into financial agreements on behalf of the company. This meeting is significant as it may impact the company’s operational flexibility and financial strategy.
More about Jiangxi Rimag Group Co., Ltd. Class H
Jiangxi Rimag Group Co., Ltd. is a joint stock company incorporated in China, primarily operating in the medical imaging industry. It focuses on providing medical imaging diagnostic services, likely targeting a market concerned with healthcare and medical diagnostics.
YTD Price Performance: -47.18%
Average Trading Volume: 87,873
Technical Sentiment Consensus Rating: Strong Buy
Learn more about 2522 stock on TipRanks’ Stock Analysis page.
